Gastric ulcers have a natural tendency towards healing, and a controlled therapeutic trial is the only reliable method for assessing the value of any method of treatment. This paper reports our experience with carbenoxolone, and confirms the studies of Doll et al. (1962 (1958) showed that stopping smoking helped to heal gastric ulcers.
; an extract of brain (Brochner-Mortensen et al., 1955) ; alkalis and continuous milk (Doll et al., 1956) . Doll and Pygott (1952) compared the effect of bed rest of in-patients with ambulant treatment of out-patients, and found that 56% of ulcers treated by bed rest healed by two-thirds or more. Doll et al. (1958) showed that stopping smoking helped to heal gastric ulcers.
In the trial of carbenoxolone reported by Doll et al. (1962) , of 30 patients receiving the drug 70% healed by two-thirds or more, while of 20 patients receiving dummy tablets 20% healed by two-thirds or more. The figure for complete healing in their trial was 37%.
Revers (1946) undertook the first clinical trial of an extract of liquorice in the treatment of gastric ulceration. He demonstrated a beneficial effect, but a large number of patients developed oedema and interest waned. Liquorice extracts contain glycyrrhizic acid ; from this may be prepared the triterpenoid glycyrrhetinic acid. The latter acid has a low solubility in body fluids, and a water-soluble derivative has been synthesized-that is, the disodium salt of glycyrrhetinic acid hydrogen succinate (carbenoxolone sodium). It differs from preparations containing liquorice extracts, where the action cannot be attributed to any one constituent.
Method
All in-patients and out-patients attending the medical clinics of the hospital in whom a gastric ulcer was demonstrated radiologically were admitted to the trial, provided there were no contraindications. A double-blind trial was adopted; the clinician and radiologist, as well as the patient, were unaware of the precise medication being administered for the first two weeks and sometimes four weeks of treatment.
Forty sets of tablets were prepared, only 35 of which were used. Half of the tablets contained 50 mg. of carbenoxolone, together with starch B.P., lactose B.P., and peppermint oil. The remaining, or " dummy," tablets were identical in appearance. The sets of tablets were intermingled and each set was given a trial number. The key to the trial tablets was kept in a sealed envelope, which was not opened until the trial was completed. When patients were admitted to the trial they were given the trial tablets by the dispensary in numerical order. In this way a random allocation of patients to the active-tablet and dummy-tablet groups was obtained.
Treatment was started with the trial tablets within five days of the barium-meal examination demonstrating the ulcer crater. The patient took the trial tablets for two weeks, the first week's dosage being two tablets thrice daily, the second week's one tablet three times daily. Patient's were asked to take a normal diet, alkalis were not routinely prescribed, and no instructions were given about smoking and drinking.
After two weeks' treatment the patient attended for a restricted barium-meal examination. If the ulcer showed signs of healing, as demonstrated by reduction in size, the trial tablets were continued, but if the ulcer was unchanged in size, or larger, the patient was given known carbenoxolone tablets 50 mg. three times daily until the ulcer was radiologically healed. Patients attended at two-weekly intervals for restricted barium-meal examinations until the ulcer crater was healed.
Clinical Assessment
In-patients were seen by one of us (L. H.) at least twice a week, and out-patients were seen weekly. All patients were invited to comment freely on their symptoms and progress, and were examined fully at weekly intervals. At the same time the weight and blood-pressure were recorded and blood was taken for estimation of the electrolytes, serum proteins, prothrombin, and cell count. An electrocardiogram was taken weekly.
The information obtained was not passed on to the radiologist, who reported the size of the ulcer every two weeks during the investigation.
General Condition.-In the patients receiving dummy tablets the general condition was unchanged. In the carbenoxolonetreated patients there was an overall feeling of well-being, occasionally amounting to euphoria. At first this was attributed to a possible steroid-like effect of carbenoxolone, but as it persisted after treatment it was presumably due to alleviation of symptoms.
Abdominal Pain. 
Radiological Assessment
The barium-meal examinations were carried out on all patients with an image intensifier and closed-circuit television. Strict precautions were taken to reduce the radiation received by the patients. The restricted barium-meal examination consisted of one or two pictures of the site of the ulcer crater, the radiographs being "coned down " to this site. The maximum diameter and depth of the ulcer crater were recorded at each examination, and the presence of other lesions such as duodenal ulcer and hiatus hernia was noted. Patients in the trial had a routine postero-anterior radiograph of the chest at the time of the first barium-meal examination, and this was repeated later in the trial if the patient complained of dyspnoea or showed clinical evidence of oedema.
Results
Thirty-five patients were admitted to the trial. One absconded and abandoned the treatment; he was subsequently found to have been taking dummy tablets. Later he responded satisfactorily to carbenoxolone but was not included in the final assessment.
The patients were divided into three groups according to their clinical progress: group A, who were free from pain and tenderness and showed a tendency to gain weight, which was maintained after treatment ceased; group B, who showed marked relief of symptoms and resolution of abdominal tenderness; and group C, who had no relief of symptoms and in whom tenderness persisted when present.
The radiological assessment was based on the size of the ulcer, the maximum diameter of the crater being used: in group 1 complete radiological healing had occurred, the ulcer crater being no longer visible; in group 2 the ulcer crater had decreased in size as shown by a reduction of the maximum diameter by 25 % or more; and in group 3 there was no decrease in the maximum diameter of the ulcer crater.
The results after two weeks are shown in Table I . No clinical assessment was made for one patient on dummy tablets after two weeks, and no radiological assessment was made for one patient receiving carbenoxolone for two weeks, as these patients were unable to attend for assessment at the times indicated. 
Analysis of Radiological Assessment Results
The numbers in each group are too small to allow a valid calculation of the significance of the difference between the two treatment groups in the three categories. Table II shows the results when the "healed" and "improved" categories are combined together. This demonstrates that healing in the patients treated with carbenoxolone is significantly greater than in those given dummy tablets (P=0.023, Fisher's test). and comparing it with that found before treatment, and assuming the square of the diameter to be the best available index of the actual ulcer area.
The average healing in the two groups (plus or minus standard error) was dummy, 50% + 13; carbenoxolone, 88% +5. The difference is again very significant (P<0.01) with the Aspin-Welch test for small samples with unequal variances (one tailed).
Complete Healing
After two weeks' treatment those patients who were not showing radiological improvement on the randomized treatments were given known carbenoxolone tablets as previously described. The patients were then radiologically examined at two-weekly intervals until healed.
Of the 34 patients in the trial eight were healed on dummy tablets alone-six after two weeks, one after four weeks, and one after six weeks. The remaining 26 received carbenoxolone tablets, either from the beginning or after the initial two-week double-blind period. The numbers of patients healed after various times on carbenoxolone therapy are shown in Table III . It will be seen that 92.3% of patients were eventually healed while on carbenoxolone therapy, 81% of these after six weeks' treatment. Side-effects Salt-and-water Retention was the most frequent and important side-effect, and occurred in 31% of patients treated with carbenoxolone. It appeared within a week in three cases, but in others was not apparent for several weeks. Oedema of the ankles and pretibial area predominated in women, with only occasional rise in blood-pressure. Men showed much greater tendency to hypertension and seldom developed oedema. These features were soon reversed on discontinuing carbenoxolone for two or three days or by giving thiazide or mercurial diuretics. These side-effects sometimes caused breathlessness on exertion, and in several cases radiological changes appeared in the lungs. One male patient with mitral incompetence developed nocturnal dyspnoea, which cleared in under 48 hours after the tablets were stopped.
A female patient developed a severe "bursting" early-morning headache at the same time as she developed oedema of the legs. There were no fundal or E.E.G. changes, and these untoward features cleared up within four days of stopping the carbenoxolone.
A 72-year-old man showed a rise in blood-pressure during the second week of treatment, and this was followed by an epileptic fit lasting three minutes. The next day there was a slight left-sided facial weakness which lasted 24 hours. His E.E.G. taken 16 hours after the fit showed an excess of low-amplitude slow activity and spikes arising from the right fronto-temporal region. A week later the second E.E.G. had improved considerably, but there were changes consistent with generalized cerebrovascular disease.
In both these cases relief of abdominal pain and discomfort occurred in two or three days. Both ulcers showed rapid healing radiologically, although each had less than two weeks' treatment. It has been our impression that ulcers in patients who show obvious salt-and-water retention heal quickly.
Potassium Deficiency.-A slight fall in serum potassium occurred in patients on prolonged treatment but never produced clinical effects. Very low potassium levels, the lowest being 2.5 mEq/l., were found in four patients who were given chlorothiazide with a small amount of potassium in a combined tablet to prevent or reverse salt-and-water retention. These patients developed frequent extrasystoles and E.C.G. changes such as a prolonged Q-T interval with flat T waves, especially in the chest leads.
Increased In the first few cases of fluid retention and rising bloodpressure 50 mg. of hydrochlorothiazide combined with 1 g. of potassium chloride was used three times a week. This diuretic regimen proved effective, but after some weeks it resulted in low levels of serum potassium in several patients. Mild cases of oedema could be corrected simply by omitting carbenoxolone for two or three days, and, furthermore, prolonged treatment without a diuretic resulted in only slight falls in the serum potassium level. Spironolactone proved inadequate as a diuretic by itself. After these findings a five-or six-day regime was used rather than prescribing large doses of potassium salts.
Those at risk from salt-and-water retention took carbenoxolone in the usual dosage, but not on one or both days at the weekend. So long as the patients took three meals a day potassium supplements did not prove necessary.
The mode of action of carbenoxolone is not as yet understood.
It is thought that the drug is rapidly absorbed in the stomach and effects healing by a direct action on the gastric mucosa.
Recent work has shown that carbenoxolone is absent from the duodenal aspirate in the rat (Parke, 1964) and from the duodenal aspirate in man (Tarnoky, 1964) . Carbenoxolone has been shown to be present in the blood, bile, and urine in man (Parke, 1964) . This would also explain the ineffectiveness of the drug, in its present form, on duodenal ulcers.
That the recurrence rate of gastric ulcer is high is clear from previously reported long-term studies. Swynnerton and Tanner (1953) found that only 23.6% were without recurrence. Malmros and Hiertonn (1949) found only 21.9% symptom-free after 10 years. Qvigstad and Romcke (1946) found only 22% of patients symptom-free after an average follow-up of eight years, excluding pyloric ulcers, which they considered separately.
Since the trial was completed 24 patients have been followed up for periods from 6 to 12 months after the ulcer had healed. Of 18 patients treated with carbenoxolone the ulcer has recurred in eight, and of six patients who healed on dummy tablets one has had a recurrence, all at the site of the original ulcer. A subsequent analysis showed that the largest ulcer to heal on dummy tablets had a diameter of 0.9 cm., and the average diameter of this group was 0.4 cm.
In an attempt to prevent recurrence a maintenance dose of 25 mg. of carbenoxolone twice daily is at present being used.
It is emphasized that the healing of a gastric ulcer is only one aspect of the management of the condition. The gastric mucosa remains unstable, and recurrence at the same or other sites is always possible. The possibility of malignant changes must be borne in mind, though there is much controversy on how often this occurs. Martin and Lewis (1949) noted that 3% of their gastric-ulcer patients died from gastric carcinoma, but Swynnerton and Tanner (1953) Attention is also drawn to the drug's side-effects, which occurred in 35 % of patients, and of which salt-and-water retention is the most important. The side-effects led to the introduction of a five-or six-day regime in which carbenoxolone was omitted on one or both days at the week-end in those at risk. Since the introduction of this regime side-effects have been much less marked and less frequent.
Carbenoxolone has a specific effect, facilitating the healing of gastric ulcer, and is not merely yet another symptomatic measure.
Frusemide (4 - (Stewart, 1965) . Frusemide may be given orally or parenterally; by either route it produces a rapid, short-lived diuresis due to inhibition of salt-and-water reabsorption in both proximal and distal portions of the renal tubule (Suzuki, Kliltsch, and Heidland, 1964 
Clinical Material and Methods
Eleven patients were studied. Each had been admitted to hospital for the treatment of oedema which had failed to improve with ordinary diuretic therapy. Relevant clinical data on these patients are shown in Table I . Of the 11 patients, one had portal hypertension, two had the nephrotic syndrome, and eight had congestive heart failure due to various causes. All but four patients had some impairment of renal function.
Each patient was weighed daily at 8 a.m., and accurate 8 a.m. to 8 a.m. fluid-balance charts were kept. The volume and sodium, potassium, and chloride content of each 24-hour collection of urine were measured. Serum and urinary electrolytes and serum urea nitrogen concentrations were determined on the Technicon AutoAnalyzer, and creatinine was measured by the method of Edwards and Whyte (1958) .
Design of Clinical Trials
All patients were given a diet containing 3 g. of salt (approximately 50 mEq of Na) and allowed 1 litre of drinking-fluids each day. The diuretic drugs were given daily at 10 a.m. in a single oral dose unless otherwise stated, except spironolactone, which was given in four equal doses daily. In trials A, B, and C only one diuretic drug was given each day.
Trial A.-Three patients were given each of four different treatments in two-day periods for 32 days. The treatments
